nevirapine has been researched along with tnk-651 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, X; Kollman, PA; Kuntz, ID; Wang, J | 1 |
| Huang, Y; Jiang, S; Li, L; Liu, C; Liu, J; Ma, L; Ouyang, Y; Qiao, K; Shao, Y; Wang, R; Wang, X; Xu, W; Zhang, J; Zhang, L; Zhang, Z | 1 |
| Cao, Y; Du, Y; Huang, Y; Jiang, S; Li, A; Li, C; Li, L; Liu, J; Liu, X; Liu, Z; Ma, L; Ouyang, Y; Qiao, K; Ran, L; Shao, Y; Tian, C; Wang, X; Wang, Z; Xu, W; Zhang, L; Zhang, Z | 1 |
3 other study(ies) available for nevirapine and tnk-651
| Article | Year |
|---|---|
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.
Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics | 2005 |
Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile.
Topics: Anti-HIV Agents; Cell Line, Tumor; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Hydrogen Bonding; Models, Molecular; Structure-Activity Relationship; Uracil | 2012 |
Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
Topics: Cell Line; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Protein Conformation; Pyridones; Reverse Transcriptase Inhibitors | 2013 |